Trypsin Inhibitors

All categories
DBCAT000157Pharmacologic class

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. A DrugBank category of 5 drugs. 2 of them are approved.

Part of
Serine Protease Inhibitors
Also known as
Inhibitors, Trypsin
Drugs

What you can answer from here — as of April 02, 2021

5DrugsEach linked to its full drug card
Listed above
14Drug targetsEvery drug–target pair in the class, with bond type
Sign in
94Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Trypsin Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In